Nektar Therapeutics
NKTR
#8305
Rank
โ‚น14.60 B
Marketcap
โ‚น79.16
Share price
-1.35%
Change (1 day)
102.61%
Change (1 year)

Revenue for Nektar Therapeutics (NKTR)

Revenue in 2024 (TTM): โ‚น7.77 Billion

According to Nektar Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น7.94 Billion. In 2023 the company made a revenue of โ‚น7.50 Billion a decrease over the revenue in the year 2022 that were of โ‚น7.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nektar Therapeutics from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น7.77 B3.57%
2023 โ‚น7.50 B-1.51%
2022 โ‚น7.61 B0.43%
2021 โ‚น7.58 B-32.18%
2020 โ‚น11.18 B36.82%
2019 โ‚น8.17 B-90.2%
2018 โ‚น83.44 B324.68%
2017 โ‚น19.64 B74.76%
2016 โ‚น11.24 B-26.7%
2015 โ‚น15.33 B20.57%
2014 โ‚น12.72 B38.26%
2013 โ‚น9.20 B106.96%
2012 โ‚น4.44 B17.56%
2011 โ‚น3.78 B-46.94%
2010 โ‚น7.12 B113.52%
2009 โ‚น3.33 B-23%
2008 โ‚น4.33 B-59.54%
2007 โ‚น10.71 B11.12%
2006 โ‚น9.64 B69.69%
2005 โ‚น5.68 B14.83%
2004 โ‚น4.94 B2.29%
2003 โ‚น4.83 B6.37%
2002 โ‚น4.54 B21.68%
2001 โ‚น3.73 B55.13%
2000 โ‚น2.40 B33.95%
1999 โ‚น1.79 B93.97%
1998 โ‚น0.92 B45.23%
1997 โ‚น0.63 B157.44%
1996 โ‚น0.24 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น2.774 T 34,831.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.126 T 64,440.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.387 T 67,729.11%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น16.85 B 112.16%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.366 T 54,879.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น1.192 T 14,918.74%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น128.35 B 1,516.03%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น7.478 T 94,058.07%๐Ÿ‡บ๐Ÿ‡ธ USA